Crossmark

Expanding access to scalp cooling therapy: a review of scalp cooling outcomes in patients who received financial assistance from a nonprofit organization

Crossref DOI link: https://doi.org/10.1007/s00403-023-02810-3

Published Online: 2024-01-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Novice, Madison

Rose, Lucy

Novice, Taylor

Darland, Allison

Dulmage, Brittany

Powers, Molly

Lo Sicco, Kristen I.
License Information

Text and Data Mining valid from 2024-01-08

Version of Record valid from 2024-01-08
More Information

Article History

Received: 5 October 2023

Revised: 17 November 2023

Accepted: 26 December 2023

First Online: 8 January 2024

Change Date: 19 January 2024

Change Type: Update

Change Details: The original online version of this article was revised to correct the author's name Lo Sicco, KI.

Declarations

:

: Three authors (Ms. Madison Novice, Dr. Taylor Novice, and Dr. Molly Powers) are co-founders of a non-profit named Cap & Conquer whose mission is to fund scalp cooling therapy for low-income cancer patients and raise awareness about the treatment. Dr. Lo Sicco has been an investigator for Regen Lab and is an investigator for Pfizer. Dr. Lo Sicco is a consultant for Pfizer and Aquis. Dr. Dulmage is a consultant for Hoth Therapeutics and Novocure.

: University of Michigan's Institutional Review Board deemed this study exempt from IRB approval.

Document is current

Any future updates will be listed below